Waters Corporation $WAT Shares Acquired by Chevy Chase Trust Holdings LLC

Chevy Chase Trust Holdings LLC grew its stake in Waters Corporation (NYSE:WAT) by 0.9% during the second quarter, HoldingsChannel reports. The firm owned 31,822 shares of the medical instruments supplier’s stock after purchasing an additional 292 shares during the quarter. Chevy Chase Trust Holdings LLC’s holdings in Waters were worth $11,107,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of WAT. OVERSEA CHINESE BANKING Corp Ltd increased its holdings in shares of Waters by 676.8% in the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 705,733 shares of the medical instruments supplier’s stock valued at $260,112,000 after purchasing an additional 614,877 shares during the period. Alliancebernstein L.P. grew its holdings in Waters by 15.7% during the first quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier’s stock worth $1,131,757,000 after acquiring an additional 416,669 shares during the period. Wellington Management Group LLP grew its holdings in Waters by 93.3% during the first quarter. Wellington Management Group LLP now owns 572,823 shares of the medical instruments supplier’s stock worth $211,125,000 after acquiring an additional 276,433 shares during the period. Nuveen LLC acquired a new position in Waters during the first quarter worth $94,028,000. Finally, Vanguard Group Inc. grew its holdings in Waters by 2.4% during the first quarter. Vanguard Group Inc. now owns 7,272,252 shares of the medical instruments supplier’s stock worth $2,680,334,000 after acquiring an additional 173,584 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Up 0.2%

WAT opened at $335.58 on Monday. The business’s fifty day moving average is $305.36 and its two-hundred day moving average is $322.73. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The company has a market cap of $19.97 billion, a price-to-earnings ratio of 30.26, a PEG ratio of 3.12 and a beta of 1.04. Waters Corporation has a one year low of $275.05 and a one year high of $423.56.

Waters (NYSE:WAT) last posted its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. Analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently weighed in on WAT. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the stock a “hold” rating in a report on Tuesday, August 5th. Redburn Partners set a $390.00 price objective on Waters in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the stock a “buy” rating in a report on Monday, August 4th. Finally, UBS Group reaffirmed a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Waters currently has an average rating of “Moderate Buy” and a consensus target price of $376.80.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.